Forest Laboratories Announces Amendment to Merger Agreement and Extends Tender Offer to Acquire Clinical Data, Inc.

Forest Laboratories FRX today announced that its indirect wholly-owned subsidiary, Magnolia Acquisition Corp, has extended the expiration date of its tender offer for all outstanding shares of common stock of, and certain outstanding notes and warrants convertible into the common stock of, Clinical Data CLDA to expire at 12:00 midnight, New York City time on Monday, April 11, 2011. Forest also today announced that it has agreed with Clinical Data to amend the Merger Agreement, dated as of February 22, 2011, among Forest, Clinical Data, FL Holding C.V., an indirect wholly-owned subsidiary of Forest, and Magnolia.